The Valley Desk

ReviewPulmonary therapyPublished

Practical Considerations for Managing Transitions from Parenteral Prostacyclins to Oral Selexipag in Pulmonary Arterial Hypertension

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

Publication record

Type
Review
Venue
Pulmonary therapy
Published
Subject terms
Pulmonary Arterial Hypertension; Selexipag; Prostacyclin Pathway Agents; Transition Protocol
PubMed ID
41952024
PubMed Central ID
PMC13287317
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal